Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

Taha Sen, Viktor Rotbain Curovic, Niels Jongs, Gozewijn D Laverman, Adriaan Kooy, Frederik Persson, Peter Rossing, Hiddo J L Heerspink

1 Citation (Scopus)
Original languageEnglish
JournalDiabetes, Obesity and Metabolism
Issue number8
Pages (from-to)2413-2418
Number of pages6
Publication statusPublished - Aug 2023


  • Humans
  • Albuminuria/drug therapy
  • Linagliptin/pharmacology
  • Hypoglycemic Agents/pharmacology
  • Inflammation/drug therapy
  • Benzhydryl Compounds/pharmacology
  • Diabetes Mellitus, Type 2/complications
  • Dipeptidyl-Peptidase IV Inhibitors
  • empagliflozin
  • inflammatory markers
  • linagliptin
  • telmisartan
  • baricitinib
  • SGLT2 inhibitor
  • JAK–STAT inhibitor
  • ARB
  • inflammation
  • DPP-4 inhibitor

Cite this